CD19-CAR-T in B-cell Malignancies Patients

Clinical trial NCT03952923 · COMPLETED

Trial details

NCT number: NCT03952923
Sponsor: Hebei Yanda Ludaopei Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Malignancy

Start date: 2019-08-01
Primary completion: 2021-01-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.